These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33378160)

  • 1. Evaluation of Surface Modified Live Biotherapeutic Products for Oral Delivery.
    Vargason AM; Anselmo AC
    ACS Biomater Sci Eng; 2023 Jun; 9(6):2868-2878. PubMed ID: 33378160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and delivery strategies for engineered live biotherapeutic products.
    Heavey MK; Durmusoglu D; Crook N; Anselmo AC
    Trends Biotechnol; 2022 Mar; 40(3):354-369. PubMed ID: 34481657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymer and Crosslinker Content Influences Performance of Encapsulated Live Biotherapeutic Products.
    Qiu K; Huang Y; Anselmo AC
    Cell Mol Bioeng; 2021 Oct; 14(5):487-499. PubMed ID: 34777606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Batch Culture Formulation of Live Biotherapeutic Products.
    Qiu K; Anselmo AC
    Adv Ther (Weinh); 2021 Feb; 4(2):. PubMed ID: 33709021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitive delivery systems and novel encapsulation technologies for live biotherapeutic products and probiotics.
    Li S; Zhang YX
    Crit Rev Microbiol; 2024 May; 50(3):371-384. PubMed ID: 37074732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and functional features of a developmentally regulated lipopolysaccharide-binding protein.
    Krasity BC; Troll JV; Lehnert EM; Hackett KT; Dillard JP; Apicella MA; Goldman WE; Weiss JP; McFall-Ngai MJ
    mBio; 2015 Oct; 6(5):e01193-15. PubMed ID: 26463160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota restoration therapies for recurrent
    DuPont HL; DuPont AW; Tillotson GS
    Therap Adv Gastroenterol; 2024; 17():17562848241253089. PubMed ID: 38800353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opportunities and Challenges in Development of Live Biotherapeutic Products to Fight Infections.
    Ducarmon QR; Kuijper EJ; Olle B
    J Infect Dis; 2021 Jun; 223(12 Suppl 2):S283-S289. PubMed ID: 33576793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probiotics, Live Biotherapeutic Products (LBPs), and Gut-Brain Axis Related Psychological Conditions: Implications for Research and Dietetics.
    Ağagündüz D; Çelik E; Cemali Ö; Bingöl FG; Özenir Ç; Özoğul F; Capasso R
    Probiotics Antimicrob Proteins; 2023 Aug; 15(4):1014-1031. PubMed ID: 37222849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of live biotherapeutic products and perspective in the treatment of inherited metabolic disease].
    Chen Z; Guo M; Zheng H
    Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1290-1303. PubMed ID: 37154306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Quantitative Systems Pharmacology Model Describing the Cellular Kinetic-Pharmacodynamic Relationship for a Live Biotherapeutic Product to Support Microbiome Drug Development.
    Renardy M; Prokopienko AJ; Maxwell JR; Flusberg DA; Makaryan S; Selimkhanov J; Vakilynejad M; Subramanian K; Wille L
    Clin Pharmacol Ther; 2023 Sep; 114(3):633-643. PubMed ID: 37218407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanobodies as potential tools for microbiological testing of live biotherapeutic products.
    Dorosky RJ; Schreier JE; Lola SL; Sava RL; Coryell MP; Akue A; KuKuruga M; Carlson PE; Dreher-Lesnick SM; Stibitz S
    AMB Express; 2024 Jan; 14(1):9. PubMed ID: 38245586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulating Oral Delivery and Gastrointestinal Kinetics of Recombinant Proteins via Engineered Fungi.
    Heavey MK; Anselmo AC
    AAPS J; 2021 May; 23(4):76. PubMed ID: 34009532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent developments in the probiotics as live biotherapeutic products (LBPs) as modulators of gut brain axis related neurological conditions.
    Ağagündüz D; Gençer Bingöl F; Çelik E; Cemali Ö; Özenir Ç; Özoğul F; Capasso R
    J Transl Med; 2022 Oct; 20(1):460. PubMed ID: 36209124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of different extraction methods on chemical compositions and biological activities of polysaccharides from Lycium barbarum].
    Zai QY; Chen HG; Xie W; Zhou X
    Zhongguo Zhong Yao Za Zhi; 2023 Jan; 48(1):60-70. PubMed ID: 36725259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review Article: Safety of Live Biotherapeutic Products Used for the Prevention of Clostridioides difficile Infection Recurrence.
    Gonzales-Luna AJ; Carlson TJ; Garey KW
    Clin Infect Dis; 2023 Dec; 77(Suppl 6):S487-S496. PubMed ID: 38051970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine Polymerization-Mediated Surface Functionalization toward Advanced Bacterial Therapeutics.
    Wang L; Liu J
    Acc Chem Res; 2024 Mar; 57(6):945-956. PubMed ID: 38422996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison on biological activities of Lycium barbarum polysaccharides extracted with five methods].
    Wang SL; Zai QY; Chen HG; Li JW; Zhou X
    Zhongguo Zhong Yao Za Zhi; 2024 Jan; 49(1):110-122. PubMed ID: 38403344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbiota-Based Live Biotherapeutic Products for
    Monday L; Tillotson G; Chopra T
    Infect Drug Resist; 2024; 17():623-639. PubMed ID: 38375101
    [No Abstract]   [Full Text] [Related]  

  • 20. Drugging the microbiome and bacterial live biotherapeutic consortium production.
    McChalicher CW; Auniņš JG
    Curr Opin Biotechnol; 2022 Dec; 78():102801. PubMed ID: 36228531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.